Experimental metastasis is suppressed in MMP-9-deficient mice
暂无分享,去创建一个
R. Suzuki | Ryuji Suzuki | Takeshi Itoh | Masatoshi Tanioka | Hidetoshi Matsuda | Hirofumi Nishimoto | Takayuki Yoshioka | Masahiro Uehira | T. Itoh | T. Yoshioka | M. Uehira | H. Nishimoto | H. Matsuda | M. Tanioka | Masatoshi Tanioka
[1] W. Stetler-Stevenson. Progelatinase A activation during tumor cell invasion. , 1994, Invasion & metastasis.
[2] S. Itohara,et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.
[3] Stetler-Stevenson Wg. Progelatinase A activation during tumor cell invasion. , 1994 .
[4] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[5] L. Liotta,et al. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. , 1989, The Journal of biological chemistry.
[6] S. Itohara,et al. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions , 1995, Neuron.
[7] S. Itohara,et al. Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient Mice* , 1997, The Journal of Biological Chemistry.
[8] J. Woessner,et al. Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] T. Yagi,et al. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] L. Liotta,et al. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.
[11] L. Matrisian,et al. Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.
[12] H. Shimada,et al. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. , 1998, Cancer research.
[13] R. Muschel,et al. Metalloproteinases in tumor progression: the contribution of MMP-9. , 1994, Invasion & metastasis.
[14] C. Bucana,et al. Cell surface properties of B16 melanoma variants with differing metastatic potential. , 1980, Cancer research.
[15] A. Nakamura,et al. Immunologic abnormalities exhibited in IL-7 transgenic mice with dermatitis. , 1998, The Journal of investigative dermatology.
[16] J. Harb,et al. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. , 1996, Cancer research.
[17] B. Nielsen,et al. 92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer , 1996, International journal of cancer.
[18] I. Hart. The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.
[19] R. Muschel,et al. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. , 1994, Journal of cell science.
[20] P. Stephens,et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.
[21] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.